Finished
Exoskeletal-Assisted Walking in SCI Acute Inpatient Rehabilitation
NCT04221373 · Icahn School of Medicine at Mount Sinai · Updated 26 Dec 2023
- What is being tested
- Ekso™ powered exoskeleton; Standard of care
- For
- Spinal Cord Injuries; Inpatient
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 32 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 30 Sept 2019, ends 13 Sept 2022. Registered 9 Jan 2020.
- Results
- Posted on the registry on 21 Dec 2023.
In the researchers' words
The purpose of this research study is to test the effect of early exoskeletal-assisted walking (EAW) training (combined into regular acute inpatient rehabilitation (AIR)) on improving functional recovery and reducing pain and inflammation. Powered exoskeletons are a technology that offer standing and walking for certain persons with spinal cord injury (SCI) who meet the using indication of the device and have been used in the chronic SCI population with positive benefits in ability to move, daily function (such as bathing and dressing), body composition (such as lean and fat tissue mass), and quality of life (QOL). Despite the potential for EAW to promote functional recovery and reduce secondary medical complications (such as urinary tract infections and pain), no reports exist on the use of exoskeletons in AIR.
Sites
- The Mount Sinai HospitalNew York, New York, United States